Sharps Technology Gross Profit

The latest gross profit for STSS is $740K as of June 2026. That compares with $-1M in the prior-year period — up 171.8% year over year. That is below the Healthcare sector average of $66B. Investors often review this figure alongside Sharps Technology's historical trend and sector peers before judging valuation or financial health.

Over the past year, STSS's gross profit moved from $-1M to $740K — a 171.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Sharps Technology's operating scale or balance-sheet position.

Against Healthcare companies, STSS currently prints $740K for gross profit, while the sector average sits near $66B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Sharps Technology's growth, margins, and balance sheet.

A gross profit figure of $740K for STSS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $66B. Explore the charts below for those layers of context.

After noting STSS's gross profit ($740K), review year-over-year change from $-1M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.